NABI BIOPHARMACEUTICALS S-8 POS 333-38866
Table of Contents

Registration No. 333-38866

As filed with the Securities and Exchange Commission on June 27, 2003.


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549


POST-EFFECTIVE AMENDMENT NO. 1
TO

FORM S-8
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933


Nabi Biopharmaceuticals


(Exact Name of Registrant as Specified in its Charter)
     
Delaware   59-1212264

 
(State or Other Jurisdiction of
Incorporation or Organization)
  (I.R.S. Employer Identification No.)
     
5800 Park of Commerce Boulevard, N.W.
Boca Raton, FL
  33487

 
(Address of Principal Executive Offices)   (Zip Code)


Nabi-Rockville Savings & Retirement Plan


(Full Title of the Plan)


     
Thomas H. McLain
Nabi Biopharmaceuticals
5800 Park of Commerce Boulevard, N.W.
Boca Raton, FL 33487
(561) 989-5800
  Copy to: Constantine Alexander, Esq.
Nutter McClennen & Fish LLP
155 Seaport Boulevard
Boston, MA 02210-2604
(617) 439-2000

(Name, Address, and Telephone Number, Including Area Code, of Agent for Service)



 


TABLE OF CONTENTS

DEREGISTRATION OF SECURITIES
SIGNATURES


Table of Contents

DEREGISTRATION OF SECURITIES

     On June 8, 2000, Nabi Biopharmaceuticals, a Delaware corporation (the “Registrant”), filed with the Securities and Exchange Commission (the “Commission”) a registration statement on Form S-8 (Registration No. 333-38866) (the “Registration Statement”) covering 100,000 shares of Common Stock, $.10 par value per share (the “Common Stock”), to be purchased pursuant to the Nabi-Rockville Savings & Retirement Plan (the “Plan”). Pursuant to Rule 416(b) under the Securities Act of 1933, as amended (the “Securities Act”), the Registration Statement also covered an indeterminate number of additional shares of Common Stock to be issued under the Plan as a result of a stock dividend, stock split, or other recapitalization. Pursuant to Rule 416(c) under the Securities Act, the Registration Statement also covered an indeterminate amount of interests to be offered or sold pursuant to the Plan.

     On January 1, 2002, the Plan was merged into the Nabi Savings & Retirement Plan. Effective as of the merger date, the offering under the Plan was terminated. The Registrant is filing this Post-Effective Amendment No. 1 to the Registration Statement (the “Amendment”) to deregister 100,000 shares of Common Stock, an indeterminate number of additional shares of Common Stock, and an indeterminate amount of interests remaining unsold at the termination of the offering.

     The Plan will file with the Commission a Form 15 to suspend the duty under Section 15(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), to file reports required by Section 13(a) of the Exchange Act with respect to the Plan interests. A duty to file reports under Section 13(a) or 15(d) will remain for the Common Stock and certain other classes of securities.

 


Table of Contents

SIGNATURES

     The Registrant. Pursuant to the requirements of the Securities Act, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Amendment to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Boca Raton, State of Florida, on this 27th day of June, 2003.

         
    NABI BIOPHARMACEUTICALS
         
    By:   /s/ Thomas H. McLain
       
        Thomas H. McLain
President and Chief Executive Officer

     Pursuant to the requirements of the Securities Act, this Amendment has been signed by the following persons in the capacities and on the dates indicated.

         
Signature   Title   Date
 
/s/ Thomas H. McLain

Thomas H. McLain
  President, Chief
Executive Officer, and
Director
  June 27, 2003
 
         
 
/s/ Mark Smith

Mark L. Smith
  Senior Vice President,
Finance, Chief Financial Officer,
Chief Accounting Officer, and
Treasurer
  June 27, 2003
 
         
 
/s/ David J. Gury

David J. Gury
  Chairman of the Board   June 27, 2003
 
         
 
                                       *

David L. Castaldi
  Director    
 
         
 
 

Geoffrey F. Cox, Ph.D.
  Director    
 
         
 
                                       *

George W. Ebright
  Director    

 


Table of Contents

         
Signature   Title   Date
 
                                       *

Richard A. Harvey, Jr.
  Director    
 
         
 
                                       *

Linda Jenckes
  Director    
 
         
 
 

Stephen G. Sudovar
  Director    


*   Signed pursuant to a power of attorney filed with the Securities and Exchange Commission on June 8, 2000.
         
/s/ David J. Gury

David J. Gury
  Attorney-in-fact   June 27, 2003

     The Plan. Pursuant to the requirements of the Securities Act, the Plan administrator has duly caused this Amendment to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Boca Raton, State of Florida, on this 27th day of June, 2003.

         
    NABI-ROCKVILLE SAVINGS & RETIREMENT PLAN
         
    By:   Nabi Biopharmaceuticals, Plan Administrator
         
    By:   /s/ Mark Smith
       
        Mark L. Smith
Senior Vice President, Finance, Chief
Financial Officer, Chief Accounting
Officer, and Treasurer